On December 9, 2014, Xiamen Zeesan Biotech Co., Ltd. (“Zeesan Biotech”, stock code: 831425) was successfully listed on the National Equities and Exchange Quotations (“NEEQ”) system.
A Xiamen-based team led by Guo Zhiqing, head of the capital markets department of the office, provided comprehensive legal counsel for Zeesan Biotech. The team also included associate Yu Xianju and trainee Peng Yanting. Their expertise was unanimously recognized by the client and participating intermediaries.
Zeesan Biotech, located in Xiamen National Torch Hi-tech Industrial Development Zone, is a hi-tech enterprise primarily engaged in the development, manufacture and sale of IVD reagents and equipment. It is the first NEEQ-listed enterprise advised by the Xiamen office.
Beijing Dacheng Law Offices, LLP ("大成") is an independent law firm, and not a member or affiliate of Dentons. 大成 is a partnership law firm organized under the laws of the People’s Republic of China, and is Dentons' Preferred Law Firm in China, with offices in more than 50 locations throughout China. Dentons Group (a Swiss Verein) ("Dentons") is a separate international law firm with members and affiliates in more than 160 locations around the world, including Hong Kong SAR, China. For more information, please see dacheng.com/legal-notices or dentons.com/legal-notices.
